(Q35188942)

7 August 2017

1 reference

title

Endothelial dysfunction: clinical strategies for treating oxidant stress (English)

1 reference

7 August 2017

0 references

Brett E Fenster

1

1 reference

7 August 2017

Philip S Tsao

series ordinal

2

1 reference

7 August 2017

Stanley G Rockson

series ordinal

3

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

7 August 2017

published in

American Heart Journal

1 reference

7 August 2017

volume

146

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

218-226

1 reference

Oxidant signaling in vascular cell growth, death, and survival : a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Expression of NADH/NADPH oxidase p22phox in human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Effects of vitamin E on endothelial function in men after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Vitamin E supplementation and cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Mechanism of NADPH oxidase activation by the Rac/Rho-GDI complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Troglitazone improves endothelial dysfunction in patients with insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Effects of troglitazone on frequency of coronary vasospastic-induced angina pectoris in patients with diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Insulin action enhancement normalizes brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Improved endothelial function with metformin in type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Effect of vitamin E on resistance vessel endothelial dysfunction induced by methionine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2802%2994796-4

10.1016/S0002-8703(02)94796-4

7 January 2021

Identifiers

DOI

1 reference

7 August 2017

1 reference